Erlotinib Terminated Phase 2 Trials for Esophageal Diseases / Neoplasms, Esophageal Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00442507Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction